Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …

An automated "bionic" pancreas that incorporates glucagon as well as insulin has shown improved blood glucose for five consecutive days in a study of patients with type 1 diabetes….

Some diabetes experts have expressed concerns about recent national guidelines on lipid management, criticizing a lack of LDL cholesterol targets and little direction for management with drugs beyond statins…. 

Even if the FDA approves Technosphere Insulin Inhalation Powder (TI) in the US, will it get recommended?…

Depression has been linked with worse survival in a 20-year observational study of patients with type 1 diabetes…. 

Diabetes patients stand to benefit from two experimental insulin therapies that could eventually replace Sanofi’s global leader Lantus, according to results from large clinical trials….  Both treatments are basal insulins, which help diabetics keep blood sugar levels under control between meals and throughout the day. Sanofi’s experimental new drug Toujeo …

A Novo Nordisk drug, IDegLira which combines its long-acting insulin degludec with its type 2 diabetes treatment Victoza, maintained superior blood sugar reduction after one year…. 

Findings suggest clinicians can prevent or delay the onset of type 2 diabetes "over a very long period of time"….

LDL cholesterol wasn’t a good predictor of cardiovascular disease in type 1 diabetes, but the total cholesterol-to-HDL ratio appeared more reliable, an observational study showed…. 

Treatment of prediabetes and prevention of type 2 diabetes reduces cardiovascular risk….